top of page

BIO International 2025: CEO Steve Favaloro introduces us to Genezen - a best-in-class CDMO with a preclinical to commercial offering

  • blonca9
  • Jun 16
  • 1 min read

From the floor of the BIO International Convention, he describes the services that Genezen offers, its growth, and how it can partner with your company to help you succeed in the cell and gene therapy space.




Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTVHQ

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Genezen_Logo_RGB.png

Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.

Learn more about Genezen

bottom of page